Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Guilin Sanjin Pharmaceutical Co Ltd

002275.SZ ✓ COMPLIANT ☆ Track — members

SZSE · Healthcare · Pharmaceuticals ·

China Small Cap Analyst: N/A

Last Close

$1.87

▼ -0.24%

Market Cap $1.10B · Vol 3.43M

Key Metrics

P/E Ratio

18.10

FWD: 13.57

Market Cap

$1.10B

Small Cap

Div Yield

3.99%

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

37.45

Momentum

Beta

0.45

vs Market

52W High

$2.34

15.89% below

52W Low

$1.77

6.44% above

Volume

3.43M

Avg 2.57M

P/B

2.54

Price-to-book

ROE

N/A

Return on equity

Free Float

21.97%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Guilin Sanjin Pharmaceutical Co Ltd (002275.SZ) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 002275.SZ pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.42%

-2.41%

-7.11%

-14.11%

YTD

-11.06%

-19.36%

-10.05%

-3.17%

Financials & Valuation

TTM · Annual

Total Revenue	$292.54M
Net Income	$61.94M
Revenue Growth (YoY)	-2.98%
Gross Margin	75.14%
Operating Margin	25.77%
Net Profit Margin	21.17%
ROE	N/A
ROA · ROIC	12.65% · 12.07%

P/E Ratio	18.10
Forward P/E (FY1)	13.57
PEG Ratio	-1.13
P/S	4.05
P/B	2.54
P/FCF	13.34
EPS Growth	N/A
Outstanding Shares	587.57M

Technical Indicators

50-Day SMA	$1.94
200-Day SMA	$2.09
RSI (14)	37.45
Beta	0.45
52-Week High	$2.34
52-Week Low	$1.77

Volume Today	3.43M
Avg Daily Volume (30D)	2.57M
Relative Volume	1.33x
Volatility (10D)	31.94
Volatility (30D)	26.10
Free Float	21.97%

Analyst Consensus

N/A

Current Price $1.87

Mean Target N/A

52W Low$1.77 52W High$2.34

Current

Target

$1.77 $2.34

Current Analyst target

· 0 analysts

Identifiers

ExchangeSZSE

FIGIBBG001T13LT2

ISINCNE100000DY9

CountryChina

Sub-IndustryAlternative Medicine

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

000538.SZ Yunnan Baiyao Group Co Ltd +1.01% 600085.SS Beijing Tong Ren Tang Co Ltd +1.98% 000423.SZ Dong-E-E-Jiao Co Ltd +1.85% 002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd +1.58% 600329.SS Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd +1.01%

Company Profile

Guilin Sanjin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of Chinese patent medicines. The Company mainly operates in the two major areas of oral and throat health and urinary health, including the prevention, self-treatment and rehabilitation of common household diseases such as cardiovascular and cerebrovascular, nervous system, respiratory system and digestive system. The Company's main products include Sanjin Tablets, Guilin Xiguashuang, Xiguashuang Throat Tablets, Xiguashuang Qingyan Lozenges, Naomaitai Capsules, Xuanyunning Tablets/Granules, Gejie Dingchuan Capsules, Yuye Jiedu Granules.